Benzinga | Nov 4, 2021 07:40AM EDT

Antares Pharma Q3 EPS $0.03, Inline, Sales $48.19M Miss $48.33M Estimate

Antares Pharma (NASDAQ:ATRS) reported quarterly earnings of $0.03 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $48.19 million which missed the analyst consensus estimate of $48.33 million by 0.29 percent. This is a 20.47 percent increase over sales of $40.00 million the same period last year.